Under Zhou Xiang’s leadership, Sichuan Neo-Green Pharmaceutical Technology Development has received a great deal of acclaim for its innovative Chinese medicine products. It is one of six national Chinese medicine enterprises approved by China’s National Medical Products Administration. The company received a national commendation for its contribution of more than 38 million yuan (US$5.9 million) worth of medicines and other materials to frontline workers during the pandemic.